Clinical Trial Update: Baroreflex Activation Therapy in Left Ventricular Assist Device Patients Study [NA]

View source ↗

Summary

A clinical trial evaluating baroreflex activation therapy in patients with left ventricular assist devices for heart failure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Medical University of South Carolina | Conditions: Congestive Heart Failure | NA | Status: WITHDRAWN